Novel methods of treating hearing loss
US-2024390323-A1 · Nov 28, 2024 · US
Sesquiterpenes for antifungal applications
US8980951B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8980951-B2 |
| Application number | US-201414159525-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 21, 2014 |
| Priority date | Jul 21, 2011 |
| Publication date | Mar 17, 2015 |
| Grant date | Mar 17, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Bicyclic sesquiterpene compounds exhibiting antifungal characteristics are formulated into antifungal compositions for use in the treatment of fungal infections in humans, animals, and plants. Particularly, sesquiterpene alcohols derived from drimane have been discovered to possess broad-spectrum antifungal characteristics. Exemplary antifungal sesquiterpene compounds include albicanol and drimenol, which have been shown effective against a number of pathogenic fungi.
First claim
Opening claim text (preview).
We claim: 1. A method for treating a fungal infection in an animal or human body comprising the step of administering to said animal or human body a composition comprising a therapeutically effective amount of one or more drimane derivatives, wherein said drimane derivatives are selected from the group consisting of: wherein R 1 is CH 2 , CHR′, S, NHR′, or O, wherein…
Assignees
Inventors
Classifications
- A61K31/045Primary
Human Necessities · mapped topic
- C07C33/14Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8980951B2 cover?
- Bicyclic sesquiterpene compounds exhibiting antifungal characteristics are formulated into antifungal compositions for use in the treatment of fungal infections in humans, animals, and plants. Particularly, sesquiterpene alcohols derived from drimane have been discovered to possess broad-spectrum antifungal characteristics. Exemplary antifungal sesquiterpene compounds include albicanol and drim…
- Who is the assignee on this patent?
- Univ Kansas State
- What technology area does this patent fall under?
- Primary CPC classification A61K31/045. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).